Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Liu, Xinxue ^a   Wong, Angela ^a   Kadri, Sudarshan R ^a   Corovic, Andrej ^a   O'Donovan, Maria ^b   Lao Sirieix, Pierre ^a   Lovat, Laurence B ^a   Burnham, Rodney W ^c   Fitzgerald, Rebecca C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c QUEEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BARRETT ESOPHAGUS; COHORT ANALYSIS; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GOLD STANDARD; HEARTBURN; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; THORAX PAIN; AGED; CLINICAL TRIAL; COMPLICATION; DEMOGRAPHY; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; YOUNG ADULT;

ADULT; AGED; BARRETT ESOPHAGUS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84899674412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094163     Document Type: Article

References (43)

1. Pohl H, Sirovich B, Welch HG (2010) Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? Cancer Epidem Biomar 19: 1468-1470.
2. Cancer Research UK. Oesophageal cancer survival statistics.
3. Natinal Cancer Institute. Surveillance Epidemiology and End Results Stat Fact Sheets: Esophagus.
4. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope? Am J Gastroenterol 98: 1627-1633. (Pubitemid 36875359)
5. Quante M, Bhagat G, Abrams JA, Marache F, Good P, et al. (2012) Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrettlike metaplasia. Cancer Cell 21: 36-51.
6. Lagergren J (2005) Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54 Suppl 1: 1-5.
7. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, et al. (2005) Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology 129: 1825-1831. (Pubitemid 41772961)
8. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, et al. (2008) Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: The Loiano-Monghidoro study. Gut 57: 1354-1359.
9. Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL (2009) Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: A community clinic-based case-control study. Am J Gastroenterol 104: 834-842.
10. Eloubeidi MA, Provenzale D (2001) Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease - A multivariable analysis in veterans. Journal of Clinical Gastroenterology 33: 306- 309. (Pubitemid 32880970)
11. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P (2005) Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 162: 454-460. (Pubitemid 41191431)
12. Ward EM, Wolfsen HC, Achem SR, Loeb DS, Krishna M, et al. (2006) Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 101: 12-17. (Pubitemid 43381703)
13. Spechler SJ, Jain SK, Tendler DA, Parker RA (2002) Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 16: 1795-1800.
14. Thukkani N, Sonnenberg A (2010) The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States. Aliment Pharmacol Ther 31: 852-861.
15. Wang A, Mattek NC, Holub JL, Lieberman DA, Eisen GM (2009) Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci 54: 964-971.
16. Anderson LA, Watson RG, Murphy SJ, Johnston BT, Comber H, et al. (2007) Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13: 1585-1594. (Pubitemid 46672669)
17. Abrams JA, Fields S, Lightdale CJ, Neugut AI (2008) Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol 6: 30-34. (Pubitemid 50008419)
18. Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, et al. (2007) Risk factors for Barrett's oesophagus: A population-based approach. Scand J Gastroenterol 42: 148-156.
19. Smith KJ, O'Brien SM, Green AC, Webb PM, Whiteman DC (2009) Current and past smoking significantly increase risk for Barrett's esophagus. Clin Gastroenterol Hepatol 7: 840-848.
20. Steevens J, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, et al. (2011) A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 20: 345- 358.
21. Corley DA, Kubo A, Levin TR, Block G, Habel L, et al. (2007) Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133: 34-41. (Pubitemid 47031134)
22. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007) Central adiposity and risk of Barrett's esophagus. Gastroenterology 133: 403-411. (Pubitemid 47187351)
23. Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, et al. (2012) Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc 75: 945-953 e942.
24. Shariff MK, Bird-Lieberman EL, O'Donovan M, Abdullahi Z, Liu X, et al. (2012) Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Gastrointest Endosc 75: 954-961.
25. Lao-Sirieix P, Boussioutas A, Kadri SR, O'Donovan M, Debiram I, et al. (2009) Non-endoscopic screening biomarkers for Barrett's oesophagus: From microarray analysis to the clinic. Gut 58: 1451-1459.
26. Kadri SR, Lao-Sirieix P, O'Donovan M, Debiram I, Das M, et al. (2010) Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 341: c4372.
27. Gerson LB, Edson R, Lavori PW, Triadafilopoulos G (2001) Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 96: 2005-2012. (Pubitemid 32660890)
28. Locke GR, Zinsmeister AR, Talley NJ (2003) Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 58: 661-670. (Pubitemid 37370477)
29. Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC (2012) A Clinical Risk Prediction Model for Barrett Esophagus. Cancer Prev Res (Phila).
30. Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, et al. (2012) Prediction of Barrett's Esophagus Among Men. Am J Gastroenterol 108: 353-362.
31. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ (2011) American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 140: 1084-1091.
32. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, et al. (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 63: 7-42.
33. Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, et al. (2012) Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: A multicenter study. Gastrointest Endosc 75: 236-241.
34. Jones R, Coyne K, Wiklund I (2007) The gastro-oesophageal reflux disease impact scale: A patient management tool for primary care. Aliment Pharm Therap 25: 1451-1459. (Pubitemid 46848895)
35. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ (2011) American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus. Gastroenterology 140: E18-E52.
36. Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM (2002) Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 122: 26-33. (Pubitemid 34049191)
37. Reid BJ, Li X, Galipeau PC, Vaughan TL (2010) Barrett's oesophagus and oesophageal adenocarcinoma: Time for a new synthesis. Nat Rev Cancer 10: 87- 101.
38. Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103: 788- 797. (Pubitemid 351406009)
39. Cooper GS, Kou TD, Chak A (2009) Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population- Based Study With Temporal Trends. American Journal of Gastroenterology 104: 1356-1362.
40. Lao-Sirieix P, Fitzgerald RC (2012) Screening for oesophageal cancer. Nat Rev Clin Oncol 9: 278-287.
41. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, et al. (2011) Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 103: 1049-1057.
42. Thrift AP, Garcia JM, El-Serag HB (2013) A Multibiomarker Risk Score Helps Predict Risk for Barrett's Esophagus. Clin Gastroenterol Hepatol.
43. Thrift AP, Kramer JR, Alsarraj A, El-Serag HB (2014) Fat Mass by Bioelectrical Impedance Analysis is not Associated With Increased Risk of Barrett Esophagus. J Clin Gastroenterol 48: 218-223.